3/29/19

American Association for Cancer Research (AACR) Annual Meeting, March 29-April 3, 2019

Poster Presentation: KYM-001, first-in-class oral IRAK4 protein degraders, induce tumor regression in a xenograft model of MYD-88 mutant ABC DLBCL alone and in combination with BTK inhibition